SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4lrh'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PNJ_A_CHDA502_0 (FERROCHELATASE, MITOCHONDRIAL)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	4 / 5	MET A 16 PRO A 93 VAL A 110 TRP A 94	None	1.45A	2pnjA-4lrhA: 0.0	2pnjA-4lrhA: 18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R2V_D_ACTD36_0 (GCN4 LEUCINE ZIPPER)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	3 / 3	SER A 174 TYR A 175 HIS A 173	FOL A 301 (-2.8A) FOL A 301 (-4.1A) None	0.66A	2r2vD-4lrhA: undetectable	2r2vD-4lrhA: 19.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KMZ_A_FOLA301_0 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	10 / 12	TYR A 60 TYR A 85 GLN A 100 SER A 101 TRP A 102 ARG A 106 HIS A 135 TRP A 138 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.5A) FOL A 301 (-4.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) None FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.49A	4kmzA-4lrhA: 35.2	4kmzA-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KMZ_A_FOLA301_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	4 / 4	ASP A 81 ARG A 103 TRP A 140 SER A 174	FOL A 301 (-2.7A) FOL A 301 (-3.2A) FOL A 301 (-3.6A) FOL A 301 (-2.8A)	0.29A	4kmzA-4lrhA: 35.2	4kmzA-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	6 / 12	PHE A 62 ASP A 81 GLY A 137 TRP A 140 TRP A 171 SER A 174	None FOL A 301 (-2.7A) FOL A 301 (-4.3A) FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-2.8A)	0.73A	4kn0A-4lrhA: 34.6	4kn0A-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	8 / 12	TYR A 60 PHE A 62 ASP A 81 TYR A 85 GLN A 100 TRP A 102 ARG A 103 TRP A 171	FOL A 301 (-3.9A) None FOL A 301 (-2.7A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-3.7A)	0.68A	4kn0A-4lrhA: 34.6	4kn0A-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN0_A_MTXA301_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	9 / 12	TYR A 60 PHE A 62 ASP A 81 TYR A 85 TRP A 102 ARG A 103 GLY A 137 TRP A 140 TRP A 171	FOL A 301 (-3.9A) None FOL A 301 (-2.7A) FOL A 301 (-4.1A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-4.3A) FOL A 301 (-3.6A) FOL A 301 (-3.7A)	0.64A	4kn0A-4lrhA: 34.6	4kn0A-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN2_A_LYAA304_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	ASP A 81 ARG A 106 HIS A 135 GLY A 137 TRP A 171	FOL A 301 (-2.7A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.7A)	0.94A	4kn2A-4lrhA: 34.8	4kn2A-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN2_A_LYAA304_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	ASP A 81 THR A 82 TYR A 85 SER A 101 TRP A 102 ARG A 103 HIS A 135 GLY A 137 TRP A 140 TRP A 171 SER A 174 TYR A 175	FOL A 301 (-2.7A) None FOL A 301 (-4.1A) FOL A 301 (-3.5A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-2.8A) FOL A 301 (-4.1A)	0.44A	4kn2A-4lrhA: 34.8	4kn2A-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN2_B_LYAB304_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	ASP A 81 ARG A 106 HIS A 135 GLY A 137 TRP A 171	FOL A 301 (-2.7A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.7A)	0.94A	4kn2B-4lrhA: 34.7	4kn2B-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN2_B_LYAB304_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	11 / 12	ASP A 81 THR A 82 TYR A 85 TRP A 102 ARG A 103 HIS A 135 GLY A 137 TRP A 140 TRP A 171 SER A 174 TYR A 175	FOL A 301 (-2.7A) None FOL A 301 (-4.1A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-2.8A) FOL A 301 (-4.1A)	0.42A	4kn2B-4lrhA: 34.7	4kn2B-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN2_C_LYAC304_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	ASP A 81 ARG A 106 HIS A 135 GLY A 137 TRP A 171	FOL A 301 (-2.7A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.7A)	0.93A	4kn2C-4lrhA: 34.7	4kn2C-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN2_C_LYAC304_1 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	ASP A 81 THR A 82 TYR A 85 SER A 101 TRP A 102 ARG A 103 HIS A 135 GLY A 137 TRP A 140 TRP A 171 SER A 174 TYR A 175	FOL A 301 (-2.7A) None FOL A 301 (-4.1A) FOL A 301 (-3.5A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-2.8A) FOL A 301 (-4.1A)	0.44A	4kn2C-4lrhA: 34.7	4kn2C-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KN2_C_LYAC304_2 (FOLATE RECEPTOR BETA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	3 / 3	TYR A 60 GLN A 100 TRP A 138	FOL A 301 (-3.9A) FOL A 301 (-4.3A) None	0.45A	4kn2C-4lrhA: 34.7	4kn2C-4lrhA: 77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_A_FOLA301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 TYR A 85 GLN A 100 SER A 101 TRP A 102 ARG A 103 ARG A 106 HIS A 135 LYS A 136 TRP A 138 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.5A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.0A) None FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.00A	4lrhA-4lrhA: 40.3	4lrhA-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_A_FOLA301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	TYR A 85 ARG A 103 ARG A 106 HIS A 135 TRP A 134	FOL A 301 (-4.1A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) None	1.33A	4lrhA-4lrhA: 40.3	4lrhA-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_A_FOLA301_1 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	3 / 3	ASP A 81 TRP A 140 SER A 174	FOL A 301 (-2.7A) FOL A 301 (-3.6A) FOL A 301 (-2.8A)	0.00A	4lrhA-4lrhA: 40.3	4lrhA-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_B_FOLB301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	6 / 12	GLN A 100 ARG A 106 HIS A 135 LYS A 136 TRP A 138 TRP A 171	FOL A 301 (-4.3A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.0A) None FOL A 301 (-3.7A)	1.39A	4lrhB-4lrhA: 37.0	4lrhB-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_B_FOLB301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 TYR A 85 GLN A 100 SER A 101 ARG A 103 ARG A 106 HIS A 135 LYS A 136 TRP A 138 TRP A 140 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.5A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.0A) None FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.58A	4lrhB-4lrhA: 37.0	4lrhB-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_B_FOLB301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	TYR A 85 ARG A 103 ARG A 106 HIS A 135 TRP A 134	FOL A 301 (-4.1A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) None	1.28A	4lrhB-4lrhA: 37.0	4lrhB-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_B_FOLB301_1 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	3 / 3	ASP A 81 TRP A 102 SER A 174	FOL A 301 (-2.7A) FOL A 301 (-4.2A) FOL A 301 (-2.8A)	0.55A	4lrhB-4lrhA: 37.0	4lrhB-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_C_FOLC301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 ASP A 81 TYR A 85 GLN A 100 TRP A 102 ARG A 103 ARG A 106 HIS A 135 TRP A 138 TRP A 140 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-2.7A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) None FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.25A	4lrhC-4lrhA: 37.2	4lrhC-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_C_FOLC301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	TYR A 85 ARG A 103 ARG A 106 HIS A 135 TRP A 134	FOL A 301 (-4.1A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) None	1.33A	4lrhC-4lrhA: 37.2	4lrhC-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_D_FOLD301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	6 / 12	ASP A 81 GLN A 100 ARG A 106 LYS A 136 TRP A 138 TRP A 171	FOL A 301 (-2.7A) FOL A 301 (-4.3A) FOL A 301 (-3.8A) FOL A 301 (-4.0A) None FOL A 301 (-3.7A)	1.44A	4lrhD-4lrhA: 37.2	4lrhD-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_D_FOLD301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 ASP A 81 TYR A 85 GLN A 100 SER A 101 TRP A 102 ARG A 103 ARG A 106 LYS A 136 TRP A 138 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-2.7A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.5A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.0A) None FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.45A	4lrhD-4lrhA: 37.2	4lrhD-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_D_FOLD301_1 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	3 / 3	HIS A 135 TRP A 140 SER A 174	FOL A 301 (-4.1A) FOL A 301 (-3.6A) FOL A 301 (-2.8A)	0.17A	4lrhD-4lrhA: 37.2	4lrhD-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_E_FOLE301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 ASP A 81 TYR A 85 GLN A 100 TRP A 102 ARG A 103 ARG A 106 HIS A 135 LYS A 136 TRP A 140 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-2.7A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.0A) FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.34A	4lrhE-4lrhA: 37.1	4lrhE-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_F_FOLF301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 TYR A 85 GLN A 100 ARG A 103 ARG A 106 HIS A 135 LYS A 136 GLY A 137 TRP A 138 TRP A 140 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.0A) FOL A 301 (-4.3A) None FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.27A	4lrhF-4lrhA: 37.6	4lrhF-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_F_FOLF301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	TYR A 85 ARG A 103 ARG A 106 HIS A 135 TRP A 134	FOL A 301 (-4.1A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) None	1.33A	4lrhF-4lrhA: 37.6	4lrhF-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_F_FOLF301_1 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	3 / 3	ASP A 81 TRP A 102 SER A 174	FOL A 301 (-2.7A) FOL A 301 (-4.2A) FOL A 301 (-2.8A)	0.58A	4lrhF-4lrhA: 37.6	4lrhF-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_G_FOLG301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 TYR A 85 GLN A 100 TRP A 102 ARG A 103 ARG A 106 LYS A 136 GLY A 137 TRP A 140 TRP A 171 SER A 174 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.0A) FOL A 301 (-4.3A) FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-2.8A) FOL A 301 (-4.1A)	0.36A	4lrhG-4lrhA: 37.1	4lrhG-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_H_FOLH301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	12 / 12	TYR A 60 TYR A 85 GLN A 100 TRP A 102 ARG A 103 ARG A 106 HIS A 135 LYS A 136 TRP A 138 TRP A 140 TRP A 171 TYR A 175	FOL A 301 (-3.9A) FOL A 301 (-4.1A) FOL A 301 (-4.3A) FOL A 301 (-4.2A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) FOL A 301 (-4.0A) None FOL A 301 (-3.6A) FOL A 301 (-3.7A) FOL A 301 (-4.1A)	0.17A	4lrhH-4lrhA: 37.4	4lrhH-4lrhA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LRH_H_FOLH301_0 (FOLATE RECEPTOR ALPHA)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	5 / 12	TYR A 85 ARG A 103 ARG A 106 HIS A 135 TRP A 134	FOL A 301 (-4.1A) FOL A 301 (-3.2A) FOL A 301 (-3.8A) FOL A 301 (-4.1A) None	1.29A	4lrhH-4lrhA: 37.4	4lrhH-4lrhA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DLV_A_5D5A930_1 (ECTONUCLEOTIDE PYROPHOSPHATASE/PHOS PHODIESTERASE FAMILY MEMBER 2)	4lrh	FOLATE RECEPTOR ALPHA (Homo sapiens)	4 / 6	SER A 132 PHE A 160 TRP A 120 TRP A 64	None	1.39A	5dlvA-4lrhA: undetectable	5dlvA-4lrhA: 13.61

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2PNJ_A_CHDA502_0","FERROCHELATASE, MITOCHONDRIAL","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",4,"MET A  16;PRO A  93;VAL A 110;TRP A  94","None","1.45A","2pnjA-4lrhA:0.0","2pnjA-4lrhA:18.53"],["2R2V_D_ACTD36_0","GCN4 LEUCINE ZIPPER","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",3,"SER A 174;TYR A 175;HIS A 173","FOL A 301 (-2.8A);FOL A 301 (-4.1A);None","0.66A","2r2vD-4lrhA:undetectable","2r2vD-4lrhA:19.81"],["4KMZ_A_FOLA301_0","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",10,"TYR A  60;TYR A  85;GLN A 100;SER A 101;TRP A 102;ARG A 106;HIS A 135;TRP A 138;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.5A);FOL A 301 (-4.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);None;FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.49A","4kmzA-4lrhA:35.2","4kmzA-4lrhA:77.36"],["4KMZ_A_FOLA301_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",4,"ASP A  81;ARG A 103;TRP A 140;SER A 174","FOL A 301 (-2.7A);FOL A 301 (-3.2A);FOL A 301 (-3.6A);FOL A 301 (-2.8A)","0.29A","4kmzA-4lrhA:35.2","4kmzA-4lrhA:77.36"],["4KN0_A_MTXA301_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",6,"PHE A  62;ASP A  81;GLY A 137;TRP A 140;TRP A 171;SER A 174","None;FOL A 301 (-2.7A);FOL A 301 (-4.3A);FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-2.8A)","0.73A","4kn0A-4lrhA:34.6","4kn0A-4lrhA:77.36"],["4KN0_A_MTXA301_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",8,"TYR A  60;PHE A  62;ASP A  81;TYR A  85;GLN A 100;TRP A 102;ARG A 103;TRP A 171","FOL A 301 (-3.9A);None;FOL A 301 (-2.7A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-3.7A)","0.68A","4kn0A-4lrhA:34.6","4kn0A-4lrhA:77.36"],["4KN0_A_MTXA301_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",9,"TYR A  60;PHE A  62;ASP A  81;TYR A  85;TRP A 102;ARG A 103;GLY A 137;TRP A 140;TRP A 171","FOL A 301 (-3.9A);None;FOL A 301 (-2.7A);FOL A 301 (-4.1A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-4.3A);FOL A 301 (-3.6A);FOL A 301 (-3.7A)","0.64A","4kn0A-4lrhA:34.6","4kn0A-4lrhA:77.36"],["4KN2_A_LYAA304_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"ASP A  81;ARG A 106;HIS A 135;GLY A 137;TRP A 171","FOL A 301 (-2.7A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.7A)","0.94A","4kn2A-4lrhA:34.8","4kn2A-4lrhA:77.36"],["4KN2_A_LYAA304_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"ASP A  81;THR A  82;TYR A  85;SER A 101;TRP A 102;ARG A 103;HIS A 135;GLY A 137;TRP A 140;TRP A 171;SER A 174;TYR A 175","FOL A 301 (-2.7A);None;FOL A 301 (-4.1A);FOL A 301 (-3.5A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-2.8A);FOL A 301 (-4.1A)","0.44A","4kn2A-4lrhA:34.8","4kn2A-4lrhA:77.36"],["4KN2_B_LYAB304_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"ASP A  81;ARG A 106;HIS A 135;GLY A 137;TRP A 171","FOL A 301 (-2.7A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.7A)","0.94A","4kn2B-4lrhA:34.7","4kn2B-4lrhA:77.36"],["4KN2_B_LYAB304_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",11,"ASP A  81;THR A  82;TYR A  85;TRP A 102;ARG A 103;HIS A 135;GLY A 137;TRP A 140;TRP A 171;SER A 174;TYR A 175","FOL A 301 (-2.7A);None;FOL A 301 (-4.1A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-2.8A);FOL A 301 (-4.1A)","0.42A","4kn2B-4lrhA:34.7","4kn2B-4lrhA:77.36"],["4KN2_C_LYAC304_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"ASP A  81;ARG A 106;HIS A 135;GLY A 137;TRP A 171","FOL A 301 (-2.7A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.7A)","0.93A","4kn2C-4lrhA:34.7","4kn2C-4lrhA:77.36"],["4KN2_C_LYAC304_1","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"ASP A  81;THR A  82;TYR A  85;SER A 101;TRP A 102;ARG A 103;HIS A 135;GLY A 137;TRP A 140;TRP A 171;SER A 174;TYR A 175","FOL A 301 (-2.7A);None;FOL A 301 (-4.1A);FOL A 301 (-3.5A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-2.8A);FOL A 301 (-4.1A)","0.44A","4kn2C-4lrhA:34.7","4kn2C-4lrhA:77.36"],["4KN2_C_LYAC304_2","FOLATE RECEPTOR BETA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",3,"TYR A  60;GLN A 100;TRP A 138","FOL A 301 (-3.9A);FOL A 301 (-4.3A);None","0.45A","4kn2C-4lrhA:34.7","4kn2C-4lrhA:77.36"],["4LRH_A_FOLA301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;TYR A  85;GLN A 100;SER A 101;TRP A 102;ARG A 103;ARG A 106;HIS A 135;LYS A 136;TRP A 138;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.5A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.0A);None;FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.00A","4lrhA-4lrhA:40.3","4lrhA-4lrhA:100.00"],["4LRH_A_FOLA301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"TYR A  85;ARG A 103;ARG A 106;HIS A 135;TRP A 134","FOL A 301 (-4.1A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);None","1.33A","4lrhA-4lrhA:40.3","4lrhA-4lrhA:100.00"],["4LRH_A_FOLA301_1","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",3,"ASP A  81;TRP A 140;SER A 174","FOL A 301 (-2.7A);FOL A 301 (-3.6A);FOL A 301 (-2.8A)","0.00A","4lrhA-4lrhA:40.3","4lrhA-4lrhA:100.00"],["4LRH_B_FOLB301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",6,"GLN A 100;ARG A 106;HIS A 135;LYS A 136;TRP A 138;TRP A 171","FOL A 301 (-4.3A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.0A);None;FOL A 301 (-3.7A)","1.39A","4lrhB-4lrhA:37.0","4lrhB-4lrhA:100.00"],["4LRH_B_FOLB301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;TYR A  85;GLN A 100;SER A 101;ARG A 103;ARG A 106;HIS A 135;LYS A 136;TRP A 138;TRP A 140;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.5A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.0A);None;FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.58A","4lrhB-4lrhA:37.0","4lrhB-4lrhA:100.00"],["4LRH_B_FOLB301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"TYR A  85;ARG A 103;ARG A 106;HIS A 135;TRP A 134","FOL A 301 (-4.1A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);None","1.28A","4lrhB-4lrhA:37.0","4lrhB-4lrhA:100.00"],["4LRH_B_FOLB301_1","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",3,"ASP A  81;TRP A 102;SER A 174","FOL A 301 (-2.7A);FOL A 301 (-4.2A);FOL A 301 (-2.8A)","0.55A","4lrhB-4lrhA:37.0","4lrhB-4lrhA:100.00"],["4LRH_C_FOLC301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;ASP A  81;TYR A  85;GLN A 100;TRP A 102;ARG A 103;ARG A 106;HIS A 135;TRP A 138;TRP A 140;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-2.7A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);None;FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.25A","4lrhC-4lrhA:37.2","4lrhC-4lrhA:100.00"],["4LRH_C_FOLC301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"TYR A  85;ARG A 103;ARG A 106;HIS A 135;TRP A 134","FOL A 301 (-4.1A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);None","1.33A","4lrhC-4lrhA:37.2","4lrhC-4lrhA:100.00"],["4LRH_D_FOLD301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",6,"ASP A  81;GLN A 100;ARG A 106;LYS A 136;TRP A 138;TRP A 171","FOL A 301 (-2.7A);FOL A 301 (-4.3A);FOL A 301 (-3.8A);FOL A 301 (-4.0A);None;FOL A 301 (-3.7A)","1.44A","4lrhD-4lrhA:37.2","4lrhD-4lrhA:100.00"],["4LRH_D_FOLD301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;ASP A  81;TYR A  85;GLN A 100;SER A 101;TRP A 102;ARG A 103;ARG A 106;LYS A 136;TRP A 138;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-2.7A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.5A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.0A);None;FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.45A","4lrhD-4lrhA:37.2","4lrhD-4lrhA:100.00"],["4LRH_D_FOLD301_1","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",3,"HIS A 135;TRP A 140;SER A 174","FOL A 301 (-4.1A);FOL A 301 (-3.6A);FOL A 301 (-2.8A)","0.17A","4lrhD-4lrhA:37.2","4lrhD-4lrhA:100.00"],["4LRH_E_FOLE301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;ASP A  81;TYR A  85;GLN A 100;TRP A 102;ARG A 103;ARG A 106;HIS A 135;LYS A 136;TRP A 140;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-2.7A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.0A);FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.34A","4lrhE-4lrhA:37.1","4lrhE-4lrhA:100.00"],["4LRH_F_FOLF301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;TYR A  85;GLN A 100;ARG A 103;ARG A 106;HIS A 135;LYS A 136;GLY A 137;TRP A 138;TRP A 140;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.0A);FOL A 301 (-4.3A);None;FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.27A","4lrhF-4lrhA:37.6","4lrhF-4lrhA:100.00"],["4LRH_F_FOLF301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"TYR A  85;ARG A 103;ARG A 106;HIS A 135;TRP A 134","FOL A 301 (-4.1A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);None","1.33A","4lrhF-4lrhA:37.6","4lrhF-4lrhA:100.00"],["4LRH_F_FOLF301_1","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",3,"ASP A  81;TRP A 102;SER A 174","FOL A 301 (-2.7A);FOL A 301 (-4.2A);FOL A 301 (-2.8A)","0.58A","4lrhF-4lrhA:37.6","4lrhF-4lrhA:100.00"],["4LRH_G_FOLG301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;TYR A  85;GLN A 100;TRP A 102;ARG A 103;ARG A 106;LYS A 136;GLY A 137;TRP A 140;TRP A 171;SER A 174;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.0A);FOL A 301 (-4.3A);FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-2.8A);FOL A 301 (-4.1A)","0.36A","4lrhG-4lrhA:37.1","4lrhG-4lrhA:100.00"],["4LRH_H_FOLH301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",12,"TYR A  60;TYR A  85;GLN A 100;TRP A 102;ARG A 103;ARG A 106;HIS A 135;LYS A 136;TRP A 138;TRP A 140;TRP A 171;TYR A 175","FOL A 301 (-3.9A);FOL A 301 (-4.1A);FOL A 301 (-4.3A);FOL A 301 (-4.2A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);FOL A 301 (-4.0A);None;FOL A 301 (-3.6A);FOL A 301 (-3.7A);FOL A 301 (-4.1A)","0.17A","4lrhH-4lrhA:37.4","4lrhH-4lrhA:100.00"],["4LRH_H_FOLH301_0","FOLATE RECEPTOR ALPHA","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",5,"TYR A  85;ARG A 103;ARG A 106;HIS A 135;TRP A 134","FOL A 301 (-4.1A);FOL A 301 (-3.2A);FOL A 301 (-3.8A);FOL A 301 (-4.1A);None","1.29A","4lrhH-4lrhA:37.4","4lrhH-4lrhA:100.00"],["5DLV_A_5D5A930_1","ECTONUCLEOTIDE PYROPHOSPHATASE\/PHOSPHODIESTERASE FAMILY MEMBER 2","4lrh","FOLATE RECEPTOR ALPHA","Homo sapiens",4,"SER A 132;PHE A 160;TRP A 120;TRP A  64","None","1.39A","5dlvA-4lrhA:undetectable","5dlvA-4lrhA:13.61"]]